HealthQuill Health
Switzerland’s pharmaceutical company, Novartis AG,  will acquire Regulus Therapeutics for about $1.7 billion to get access to a drug to treat a genetic kidney disease called autosomal dominant polycystic kidney disease.
Drugs Health Pharma

Novartis buys Regulus for $1.7b to grab genetic kidney disease drug

HQ Team April 30, 2025: Switzerland’s pharmaceutical company, Novartis AG,  will acquire Regulus Therapeutics for about $1.7 billion to get access to a.

Read More
Johnson & Johnson’s immune disorder drug has been approved by the US Food and Drug Administration for the treatment of generalised myasthenia gravis (gMG) — a rare disease that causes muscle weakness and affects daily activities like chewing, swallowing, speaking, and breathing.
Drugs Health Pharma

US regulator approves Johnson & Johnson’s immune disorder drug

HQ Team April 30, 2025: Johnson & Johnson’s immune disorder drug has been approved by the US Food and Drug Administration for the.

Read More
Scientists in Britain have invented a material that allows teeth to be grown in a laboratory, a breakthrough which can replace painful dental implants and root canal treatments in the future.
Drugs Health Research

Scientists grow teeth in laboratory, future for implants, root canals uncertain

HQ Team April 30, 2025: Scientists in Britain have invented a material that allows teeth to be grown in a laboratory, a breakthrough.

Read More
A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold this year until April 18, in the American region, according to two global health agencies.
Drugs Health Medical

In Europe measles up 10-fold last year, Americas region up by 11-fold in 2025

HQ Team April 29, 2025: A ten-fold increase in measles cases was reported from Europe last year, while the numbers shot up 11-fold.

Read More
British-Swedish pharmaceutical company AstraZeneca Plc. has discontinued its prostate cancer trial as it failed to meet the goal of the radiographic progression-free survival target in test patients.
Drugs Health Pharma

AstraZeneca stops prostate cancer trial, Q1 revenue up 10% to $13.6b

HQ Team April 29, 2025: British-Swedish pharmaceutical company AstraZeneca Plc. has discontinued its prostate cancer trial as it failed to meet the goal.

Read More
A zamorin, an ailing British judge, and a group of physicians played crucial roles in establishing the world’s first Ayurvedic hospital in 1902.
Drugs Health Opinion

How a zamorin, a British judge, helped build world’s first ayurvedic hospital

HQ Team April 27, 2024: A zamorin, an ailing British judge, and a group of physicians played crucial roles in establishing the world’s.

Read More
Climate Health Research

UN for new equity-based, resilient model for Asia-Pacific megacities 

HQ Team April 27, 2025: As the climate crisis pushes many of Asia’s sprawling megacities to their limits, a UN body has called.

Read More
Johnson & Johnson’s investigational treatment to help people with a specific type of early-stage bladder cancer has shown 80% of the patients to be free of cancer for up to nine months, and 94% were able to avoid surgical removal of the organ after a year of follow-up.
Drugs Health Pharma

J&J’s trial drug for a type of bladder cancer helps avoid organ removal 

HQ Team April 27, 2025: Johnson & Johnson’s investigational treatment to help people with a specific type of early-stage bladder cancer has shown.

Read More
Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health Organization.
Drugs Health Pharma

Uganda declares Ebola disease outbreak to be over, WHO says

HQ Team April 26, 2025: Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health.

Read More
More than 84% of 345 information technology workers surveyed in an Indian city suffer from non-alcoholic fatty liver disease due to sedentary lifestyles, posing a significant health challenge, according to a study.
Drugs Health Research

In Hyderabad, India, 84% of IT workers have non-alcoholic fatty liver

HQ Team April 24, 2025: More than 84% of 345 information technology workers surveyed in an Indian city suffer from non-alcoholic fatty liver.

Read More